These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1644331)

  • 1. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
    Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Komatsubara T; Matsuzawa Y; Okamoto M
    Am J Gastroenterol; 1993 Jul; 88(7):1076-80. PubMed ID: 8317409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
    Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum phospholipases A2 in patients undergoing panproctocolectomy because of severe ulcerative colitis.
    Haapamäki MM; Grönroos JM; Pekkala E; Jokilammi-Siltanen A; Irjala K; Lertola K; Nevalainen TJ
    Eur J Clin Chem Clin Biochem; 1997 Oct; 35(10):749-54. PubMed ID: 9368792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma viscosity in inflammatory bowel disease.
    Lobo AJ; Jones SC; Juby LD; Axon AT
    J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
    Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
    Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease.
    Haapamäki MM; Grönroos JM; Nurmi H; Söderlund K; Peuravuori H; Alanen K; Nevalainen TJ
    Clin Chem Lab Med; 1998 Oct; 36(10):751-5. PubMed ID: 9853800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase A2 in serum and colonic mucosa in ulcerative colitis.
    Haapamäki MM; Grönroos JM; Nurmi H; Irjala K; Alanen KA; Nevalainen TJ
    Scand J Clin Lab Invest; 1999 Jul; 59(4):279-87. PubMed ID: 10463466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing acute phase responses in Crohn's disease and ulcerative colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
    Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme in Crohn's disease and ulcerative colitis.
    Silverstein E; Fierst SM; Simon MR; Weinstock JV; Friedland J
    Am J Clin Pathol; 1981 Feb; 75(2):175-8. PubMed ID: 6258421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum phospholipase A(2) IIA levels and histological activity in patients with ulcerative colitis.
    Yamaguchi O; Sugimura K; Ishizuka K; Suzuki K; Hasegawa K; Ohtsuka K; Honma T; Asakura H
    Int J Colorectal Dis; 2002 Sep; 17(5):311-6. PubMed ID: 12172924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease.
    Olaison G; Sjödahl R; Tagesson C
    Digestion; 1988; 41(3):136-41. PubMed ID: 3224765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiol methyltransferase activity in inflammatory bowel disease.
    Roediger WE; Babidge WJ
    Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.